Tizanidine: Another tool in the management of spasticity

Journal of Head Trauma Rehabilitation

Volumn 12, Issue 5, 1997, Pages 93-97

  Kaplan, Mark S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CLONIDINE; DANTROLENE; DIAZEPAM; NEW DRUG; TIZANIDINE;

AMNESIA; ANIMAL MODEL; ATAXIA; CONSTIPATION; DEPRESSION; DIARRHEA; DROWSINESS; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DEPENDENCE; DRUG METABOLISM; FATIGUE; HEPATITIS; HUMAN; HYPOTENSION; INSOMNIA; MUSCLE WEAKNESS; NAUSEA; NONHUMAN; ORAL DRUG ADMINISTRATION; PARESTHESIA; PRURITUS; RASH; REVIEW; SEDATION; SEIZURE; SEIZURE SUSCEPTIBILITY; SPASTICITY; SUSTAINED RELEASE PREPARATION; TENSION HEADACHE; VERTIGO; XEROSTOMIA;

EID: 0030697258     PISSN: 08859701     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001199-199710000-00009     Document Type: Review

References (12)

1. Coward DM. Tizanidine: neuropharmacology and mechanism of action. Neurology. 1994;44(suppl 9):S6-10; discussion S10-1.
2. Emre M, Leslie GC, Muir C, Part NJ, Pokorny R, Roberts RC. Correlations between dose, plasma concentrations, and antispastic action of tizanidine (Sirdalud). J Neurol Neurosurg Psychiatry. 1994;57(11): 1355-1359.
3. Bes A, Eyssette M, Pierrot-Deseilligny E, Rohmer F, Warter JM. A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia. Curr Med Res Opin. 1988;10(10): 709-718.
4. Medici M, Pebet M, Ciblis D. A double-blind, long-term study of tizanidine ('Sirdalud') in spasticity due to cerebrovascular lesions. Curr Med Res Opin. 1989;11(6):398-407.
5. Wallace JD. Summary of combined clinical analysis of controlled clinical trials with tizanidine. Neurology. 1994;44(suppl 9):S60-8; discussion S68-9.
6. Miettinen TJ, Kanto JH, Salonen MA, Scheinin M. The sedative and sympatholytic effects of oral tizanidine in healthy volunteers. Anesth Analg. 1996;82(4): 817-820.
7. Taittonen M, Raty H, Kirvela O, Aantaa R, Kanto J. The metabolic effects of oral tizanidine in healthy volunteers. Acta Anaesth Scan. 1995;39(5):628-632.
8. Shimomura T, Awaki E, Kowa H, Takahashi K. Treatment of tension-type headache with tizanidine hydrochloride: its efficacy and relationship to the plasma MHPG concentration. Headache. 1991;31(9):601-604.
9. Ishizuki M, Yanagisawa M. Antinociceptive effects of tizanidine, diazepam and eperisone in isolated spinal cord-tail preparations of newborn rat. Pain. 1992; 48(1):101-106.
10. Lang AE, Riley DE. Tizanidine in cranial dystonia. Clinical Neuropharm. 1992;15(2):142-147.
11. Berry H, Hutchinson DR. Tizanidine and ibuprofen in acute low-back pain: results of a double-blind multi-centre study in general practice. J Int Med Res. 1988;16(2):83-91.
12. De Sarro GB, Croucher MJ, Meldrum BS. Anticonvulsant actions of DS 103-282. Pharmacological studies in rodents and the baboon, Papio papio. Neuropharmacology. 1984;23(5):525-530.